Total 7
| Number | Title | Date |
| 7 |
Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA
 donghee.im
|
2024.07.31
|
Votes 0
|
Views 268
|
2024.07.31 |
| 6 |
Prestige Biologics hires former Lonza official as new director
 IPR
|
2024.05.23
|
Votes 0
|
Views 485
|
2024.05.23 |
| 5 |
Prestige Biologics achieves ISO certifications, enhancing its global position as a leading ESG CDMO company
IPR
|
2024.01.30
|
Votes 0
|
Views 713
|
2024.01.30 |
| 4 |
Prestige Biologics signed 5-year CMO service agreement with Celltrion
IPR
|
2024.01.17
|
Votes 0
|
Views 767
|
2024.01.17 |
| 3 |
Prestige Biologics enters into MOU with Aurigene Pharmaceutical Services Limited to explore collaboration in CDMO market
IPR
|
2023.09.22
|
Votes 0
|
Views 736
|
2023.09.22 |
| 2 |
Prestige Biopharma and Imagion Biosystems sign an MOU, developing early pancreatic cancer diagnosis platform
IPR
|
2023.08.11
|
Votes 0
|
Views 684
|
2023.08.11 |
| 1 |
Prestige Biopharma joins CancerX as a member
IPR
|
2023.07.18
|
Votes 0
|
Views 741
|
2023.07.18 |
